Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
ROCHE is touting prospective new drugs from its long-underperforming Swiss-led research unit after years of leaning on its California-based Genentech arm to restock its medicine cabinet.
This year, the Swiss drugmaker - the top global spender in pharmaceutical research and...